[1]JournalofMedicinalChemistry,2002,vol.45,p.5755-5775
[2]Patent:US6613942,2003,B1
[3]Patent:WO2007/139464,2007,A1.Locationinpatent:Page/Pagecolumn43-44
[4]Patent:WO2009/97992,2009,A1.Locationinpatent:Page/Pagecolumn63-64
2417-72-3
6232-88-8
2417-75-6
113023-73-7
56358-60-2
208041-90-1 | H-ARG-SER-ARG-THR-ARG-GLN-PHE-TYR-GLY-LEU-MET-NH2 | AA00BCPO | MFCD06659096
219500-09-1 | 2,4-Difluorophenyl 4-(chloromethyl)benzoate | AA00BCUV | MFCD00116750
2436-04-6 | 7-Methoxytryptamine | AA00BD0N | MFCD01115208
2589-74-4 | 1-(4-Hydroxyphenyl)dodecan-1-one | AA00BD5L | MFCD00020172
219821-18-8 | (S)-4-Benzyl-1,3-thiazolidine-2-one | AA00BDCI | MFCD08436194
213018-92-9 | (S)-(+)-2-Chlorophenylglycine methyl ester, HCl | AA00BDJV | MFCD07368257
215917-99-0 | (R)-3-Hydroxymethyl-4-Boc-morpholine | AA00BDQT | MFCD06799477
218269-34-2 | Carboxymethyl-β-Cyclodextrin | AA00BDYU | MFCD30534340
27415-25-4 | 8-ISO PROSTAGLANDIN E2 | AA00BE6J | MFCD00065747
269410-01-7 | 1,3-Dimethyluracil-5-boronic acid pinacol ester | AA00BE9Y | MFCD07781230